Product
Adbelimumab
1 clinical trial
2 indications
Indication
Pancreatic CancerIndication
Neoadjuvant TherapyClinical trial
A Single-arm, Single-center, Exploratory Study of Adbelizumab Combined With Chemotherapy for Neoadjuvant Therapy in Resectable Pancreatic CancerStatus: Recruiting, Estimated PCD: 2024-12-01